Market Insights Health OTC Pharmaceuticals

Digestives & Intestinal Remedies - South Africa

South Africa

In South Africa, the revenue generated in the Digestives & Intestinal Remedies market market is estimated to be €107.20m in 2024.
It is projected to experience an annual growth rate of 1.85% (CAGR 2024-2029).
When compared globally, in China leads the market with revenues of €4,087.00m in 2024.
In terms of per person revenues, in South Africa generates €1.76 in 2024.
The Digestives & Intestinal Remedies market in South Africa is experiencing a surge in demand for natural and herbal remedies.

Key regions: Canada, United States, Australia, Brazil, Japan

Mercado

Región

Comparación de regiones

Moneda

Analyst Opinion

The Digestives & Intestinal Remedies market in South Africa is experiencing significant growth due to changing customer preferences, emerging trends, and local special circumstances.

Customer preferences: Customers in South Africa are increasingly seeking natural and herbal remedies for digestive and intestinal issues. They are becoming more conscious about the ingredients used in these products and are looking for options that are free from artificial additives and preservatives. This shift in preferences is driving the demand for organic and plant-based digestive remedies in the market.

Trends in the market: One of the key trends in the Digestives & Intestinal Remedies market in South Africa is the rising popularity of probiotics. Probiotics are live bacteria and yeasts that are beneficial for gut health. They help in maintaining a healthy balance of bacteria in the digestive system and can alleviate symptoms of digestive disorders such as bloating, constipation, and diarrhea. The increasing awareness about the benefits of probiotics has led to a surge in demand for probiotic supplements and foods in the market.Another trend in the market is the growing demand for digestive enzymes. Digestive enzymes are substances produced by the body that help break down food and facilitate digestion. However, some individuals may have insufficient enzyme production, leading to digestive problems. As a result, there is a rising demand for digestive enzyme supplements that can aid in the digestion process and improve overall gut health.

Local special circumstances: South Africa has a high prevalence of gastrointestinal disorders such as irritable bowel syndrome (IBS) and acid reflux. These conditions affect a significant portion of the population and contribute to the demand for digestive and intestinal remedies in the market. Furthermore, the country's diverse population, with various cultural and dietary practices, also influences the demand for different types of digestive remedies.

Underlying macroeconomic factors: The growing Digestives & Intestinal Remedies market in South Africa is also supported by favorable macroeconomic factors. The country's improving healthcare infrastructure and rising disposable incomes have made healthcare products more accessible to the population. Additionally, the increasing urbanization and adoption of a Westernized lifestyle have led to changes in dietary habits, resulting in a higher incidence of digestive issues and subsequently driving the demand for remedies in the market.In conclusion, the Digestives & Intestinal Remedies market in South Africa is witnessing growth due to changing customer preferences towards natural and herbal products, emerging trends such as probiotics and digestive enzymes, local special circumstances including a high prevalence of gastrointestinal disorders, and underlying macroeconomic factors such as improving healthcare infrastructure and rising disposable incomes.

Methodology

Data coverage:

Data encompasses B2C spend. Figures are based on the OTC Pharmaceuticals market values, representing revenues generated by both product sales which take place exclusively in pharmacies and products which can be purchased elsewhere. Sales by hospitals are not included.

Modeling approach / Market size:

Market sizes are determined by a combined top-down and bottom-up approach, based on a specific rationale for each market market. As a basis for evaluating markets, we use data from national statistical offices, international institutions, trade associations, and self-medication associations. Next, we use relevant key market indicators and data from country-specific associations, such as consumer healthcare spending, out-of-pocket healthcare expenditure, health system accessibilities, and GDP. This data helps us estimate the market size for each country individually.

Forecasts:

In our forecasts, we apply diverse forecasting techniques. The selection of forecasting techniques is based on the behavior of the particular market. For example, forecasts are based on historical developments, current trends, and key market indicators, using advanced statistical methods.

Additional notes:

Data is modeled in US$ using current exchange rates. The market is updated twice per year in case market dynamics change. The impact of the COVID-19 pandemic is considered at a country-specific level. Whereas this market covers only OTC drugs, the Statista Pharmaceuticals market covers both OTC and prescription drugs.